CERKL is Upregulated in Cutaneous Squamous Cell Carcinoma and Maintains Cellular Sphingolipids and Resistance to Oxidative Stress.

Meyer, J M; Lee, E; Celli, A; Park, K; Cho, R; Lambert, W; Pitchford, M; Gordon, M; Tsai, K; Cleaver, J; Arron, S T; Mauro, T M.

Afiliação

Meyer JM; Dermatology Service, VA Medical Center, Department of Dermatology, UC San Francisco, CA, USA.
Lee E; Dermatology Service, VA Medical Center, Department of Dermatology, UC San Francisco, CA, USA.
Celli A; Dermatology Service, VA Medical Center, Department of Dermatology, UC San Francisco, CA, USA.
Park K; Dermatology Service, VA Medical Center, Department of Dermatology, UC San Francisco, CA, USA.
Cho R; Department of Dermatology, UC San Francisco, CA, USA.
Lambert W; Pathology and Laboratory Medicine, Rutgers University, Newark, NJ, USA.
Pitchford M; Dermatology Service, VA Medical Center, Department of Dermatology, UC San Francisco, CA, USA.
Gordon M; Dermatology Service, VA Medical Center, Department of Dermatology, UC San Francisco, CA, USA.
Tsai K; Moffitt Cancer Center, Tampa, FL, USA.
Cleaver J; Departments of Dermatology and Pharmaceutical Chemistry, UC San Francisco, CA, USA.
Arron ST; Dermatology Service, VA Medical Center, Department of Dermatology, UC San Francisco, CA, USA.
Mauro TM; Dermatology Service, VA Medical Center, Department of Dermatology, UC San Francisco, CA, USA.

Br J Dermatol ; 2020 Dec 03.

Article em En | MEDLINE | ID: mdl-33270220

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article